Business, energy, technology, markets and global industry news from Business News Today

EyeBio

PharmaDeviceNews EyeBio
Ingenia Therapeutics’ dual Prix Galien USA and Korea nominations add visibility to the newly listed biotech as attention turns to its TIE2-based vascular therapeutics pipeline, including MK-8748 and IGT-303. Representative image.
Pharma & Biotech

Ingenia Therapeutics has two Prix Galien nominations, but its real test begins after the KOSDAQ IPO

Ingenia Therapeutics gains dual Prix Galien nominations as its KOSDAQ debut puts MK-8748, IGT-303 and the broader TIE2 pipeline under scrutiny.

Read More